|
|
 |
|
|
India Biosimilar Market Analysis by Bharat Book Bureau
|
|
|
India Biosimilar Market Analysis |
|
|
|
|
|
Business,Marketing,Finance & Investment
|
|
As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities. Firms are developing their capabilities by either forming partnerships with R&D-intensive firms or outsourcing to upcoming Indian contract research organizations (CROs). Domestic manufacturers have a cost advantage (lower facility and development costs) than peers in developed countries. Moreover, Indian firms seem keen on repeating their successes achieved in developing and commercializing biosimilars. They are increasingly partnering with large multinational corporations for clinical trials, regulatory approval processes in the EU/US, and marketing to physicians as well as consumers. http://www.bharatbook.com/healthcare-market-research-reports/india-biosimilar-market-analysis.html
Launching biosimilar products in India also provides firms with an advantage to develop their post-marketing safety and efficacy data. This is specifically significant for biosimilar products as even minor changes in manufacturing processes may lead to serious health issues. One of the key challenges regarding biosimilar products is immunogenicity. Studies that compare innovator biologics and biosimilars often report differences in aggregate levels, protein concentration, stability, conformational states, and impurity profiles. Nevertheless, the biosimilar market is still nascent to gauge which of these differences is significant in determining the safety and efficacy impacts.
The Indian biosimilar market includes product segments such as insulin, erythropoietin, GCSF, hormones, interferon alpha, thrombolytics, plasma proteins, vaccines, and others. Of these, insulin is the largest segment of the biosimilar market followed by erythropoietin and GCSF. In 2011, there were about 15 epoetin, 8 G-CSF and 4 insulin biosimilars available in the Indian market. The acceptability of biosimilars is higher in the domestic market. Biosimilar substitution is automatic and can take place as soon as a biosimilar is launched.
“India Biosimilar Market Analysis” research report by KuicK research gives detailed insight on various aspects related the biosimilar market in India like Market Overview, Biosimilar Pipeline Analysis, Biosimilar Development Capabilities of Indian Players, detailed insight into recently announce Guidelines for the Development & Marketing of Biosimilar and competitive landscape.
Table of Contents
1. India Biosimilar Market Overview
2. Indian Market for Biosimilar by Drug Class
3. Biosimilar Pipeline Analysis
4. Biosimilar Development Capabilities of Indian Players: Partnerships & Acquisitions
4.1 Mergers & Acquisitions
4.2 Development & Marketing Partnership
4.2.1 Dr. Reddy’s Laboratories & Merck Serono
4.2.2 Biocon & Mylan Inc
4.2.3 Ranbaxy & Pfenex
5. Factors Driving the Market
5.1 Regulatory Framework for Biosimilars
5.2 Cost Advantage of Biosimilar Development
5.3 Biologics Patent Expiration
5.4 Cost Saving to Healthcare System
6. Guidelines for Development & Marketing of Biosimilar
6.1 Fundamental Principles for Manufacturing of Biosimilar
6.1.1 Reference Biologic
6.1.2 Biosimilar Development Process
6.1.3 Quality Considerations for Biosimilar
6.1.4 Quality Comparison Between Biosimilar & Reference Biologic
6.2 Preclinical Pharmacodynamic & Toxicology Studies
6.3 Pharmacokinetic & Pharmacodynamic Studies for Conducting Clinical Trial
6.4 Approval for Marketing of Biosimilar
6.5 Pharmacovigilance & Adverse Drug Reaction Reporting
7. Indian Biosimilar Market Future Outlook
7.1 Domestic Market Expansion
7.2 Contract Manufacturing Opportunity
8. Indian Biosimilar Drugs to Enter the US & European Market
9. Competitive Landscape
9.1 Dr.Reddy's Labs (DRL)
9.2 Intas Pharmaceuticals Ltd.
9.3 Biocon Limited
9.4 Wockhardt Limited
9.5 Shantha Biotechnics Limited
9.6 Reliance Life Sciences
9.7 Cipla
List of Figures
Figure 1-1: India Biosimilar Market Sales (US$ Million), 2011-2015
Figure 2-1: Biosimilar Market by Segment, 2011
List of Tables
Table 2-1: Biosimilar Product by Indian Company
Table 5-1: Major Drug Patent Expiry by Indications, 2011
Table 5-2: Major Drug Patent Expiry by Indications, 2012
Table 5-3: Major Drug Patent Expiry by Indications, 2013
Table 5-4: Major Drug Patent Expiry by Indications, 2014
Table 5-5: Major Drug Patent Expiry by Indications, 2015
Table 8-1: Approved Biosimilar in Europe
For more information kindly visit :
India Biosimilar Market Analysis Or
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
http://researchbook.typepad.com/blog/
http://healthcareraj.blogspot.com/
Related Articles -
Healthcare, Biosimilar, Drug, Medicine, Medical, Market Research Reports,
|
Rate This Article  |
|
|
|
|
|
Do you Agree or Disagree? Have a Comment? POST IT!
| Reader Opinions |
|
|
|
|
|
|
|
|
|
| Author Login |
|
|
 |
Advertiser Login
ADVERTISE HERE NOW!
Limited Time $60 Offer!
90 Days-1.5 Million Views
|
|
STEPHEN BYE
Steve Bye is currently a fiction writer, who published his first novel, ‘Looking Forward Through the...more
|
|
|
|
|
TIM FAY
After 60-plus years of living, I am just trying to pass down some of the information that I have lea...more
|
|
|
|
|
GENE MYERS
Author of four books and two screenplays; frequent magazine contributor. I have four other books "in...more
|
|
|
|
|
LAURA JEEVES
At LeadGenerators, we specialise in content-led Online Marketing Strategies for our clients in the t...more
|
|
|
|
|
ALEX BELSEY
I am the editor of QUAY Magazine, a B2B publication based in the South West of the UK. I am also the...more
|
|
|
|
|
SUSAN FRIESEN
Located in the lower mainland of B.C., Susan Friesen is a visionary brand strategist, entrepreneur, ...more
|
|
|
|
|
SHALINI MITTAL
A postgraduate in Fashion Technology. Shalini is a writer at heart! Writing for her is an expression...more
|
|
|
|
|
ADRIAN JOELE
I have been involved in nutrition and weight management for over 12 years and I like to share my kn...more
|
|
|
|
|
JAMES KENNY
James is a Research Enthusiast that focuses on the understanding of how things work and can be impro...more
|
|
|
|
